Research

Hormonal

The ketone body β-hydroxybutyrate (βHB) inhibits glucose-induced GLP-1 secretion in enteroendocrine cells, with human jejunal enteroids showing sensitivity at much lower doses (10 mM) than murine cell lines (100 mM).

This research suggests that high concentrations of ketone bodies in the gut can suppress the release of GLP-1, a hormone that helps manage blood sugar and signals fullness. While this is a laboratory finding using human gut cells, it implies that metabolic states with high local ketone production (such as during fasting or specific dietary patterns) might alter how your body responds to carbohydrates by reducing this specific hormonal signal.

ModerateRefutesMEDIUM confidence
Results demonstrated βHB had a significant inhibitory effect on glucose-induced GLP-1 secretion at a dose of 100 mM in GLUTag cells. In differentiated human jejunal enteroid monolayers, glucose-induced secretion of GLP-1 was inhibited at a much lower dose of 10 mM βHB.
Erik Elebring et al. · Journal of Molecular Endocrinology · 2023

Why this rating

The study uses rigorous in vitro models including human-derived enteroids, but lacks in vivo human clinical data.

Source

βHB inhibits glucose-induced GLP-1 secretion in GLUTag and human jejunal enteroids

Erik Elebring et al. · Journal of Molecular Endocrinology · 2023

DOI 10.1530/jme-22-0115

mechanism_onlyCited 6×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →